ALBANY, N.Y.--(BUSINESS WIRE)--Albany Molecular Research, Inc. (NASDAQ: AMRI) today reported financial results for the quarter ended March 31, 2007.
Financial highlights for the first quarter and other recent events include:
Diluted EPS of $0.10, compared to $0.06 in Q1 2006
